Memorandum from NZSG

Posted Thursday April 6, 2023

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website

Gallery

Related Articles

NZSG-NZgNC Annual Scientific Meeting Call for Abstracts Now Open

Tuesday May 20, 2025

Abstract submissions are now open and close at 5pm on Friday 8 August 2025.

Grants_Research Events + 1 More

Read more »

Pharmac Consultation: Proposal to fully fund liquid nutrition replacements for adults with Crohn's disease requiring EEN

Sunday May 18, 2025

Please consider submitting your feedback as an individual or as a joint submission between the gastroenterology and the ...

News

Read more »

IBD Research Review Issue 70

Tuesday May 13, 2025

Read about the latest IBD research and upcoming conferences.

Events News + 1 More

Read more »